These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10901232)

  • 21. Tumor reduction in vivo after adenoviral mediated gene transfer of the herpes simplex virus thymidine kinase gene and ganciclovir treatment in human head and neck squamous cell carcinoma.
    Goebel EA; Davidson BL; Graham SM; Kern JA
    Otolaryngol Head Neck Surg; 1998 Oct; 119(4):331-6. PubMed ID: 9781985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
    Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bystander effect-mediated therapy of experimental brain tumor by genetically engineered tumor cells.
    Namba H; Tagawa M; Iwadate Y; Kimura M; Sueyoshi K; Sakiyama S
    Hum Gene Ther; 1998 Jan; 9(1):5-11. PubMed ID: 9458237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
    Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
    Niranjan A; Moriuchi S; Lunsford LD; Kondziolka D; Flickinger JC; Fellows W; Rajendiran S; Tamura M; Cohen JB; Glorioso JC
    Mol Ther; 2000 Aug; 2(2):114-20. PubMed ID: 10947938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.
    Andreansky S; Soroceanu L; Flotte ER; Chou J; Markert JM; Gillespie GY; Roizman B; Whitley RJ
    Cancer Res; 1997 Apr; 57(8):1502-9. PubMed ID: 9108452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulation of glioma cells after gene therapy: induction of major histocompatibility complex class I but not class II antigen in vitro.
    Parsa AT; Chi JH; Hurley PT; Jeyapalan SA; Bruce JN
    Neurosurgery; 2001 Sep; 49(3):681-8; discussion 688-9. PubMed ID: 11523680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect".
    Chen CY; Chang YN; Ryan P; Linscott M; McGarrity GJ; Chiang YL
    Hum Gene Ther; 1995 Nov; 6(11):1467-76. PubMed ID: 8573619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient expression of SV 40 large T antigen by Cre/LoxP-mediated site-specific deletion in primary human tumor cells.
    Li LP; Schlag PM; Blankenstein T
    Hum Gene Ther; 1997 Sep; 8(14):1695-700. PubMed ID: 9322872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
    Pulkkanen KJ; Parkkinen JJ; Laukkanen JM; Kettunen MI; Tyynela K; Kauppinen RA; Ala-Opas MY; Yla-Herttuala S
    Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models.
    Eastham JA; Chen SH; Sehgal I; Yang G; Timme TL; Hall SJ; Woo SL; Thompson TC
    Hum Gene Ther; 1996 Mar; 7(4):515-23. PubMed ID: 8800746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
    Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel animal glioma models that separately exhibit two different invasive and angiogenic phenotypes of human glioblastomas.
    Inoue S; Ichikawa T; Kurozumi K; Maruo T; Onishi M; Yoshida K; Fujii K; Kambara H; Chiocca EA; Date I
    World Neurosurg; 2012 Dec; 78(6):670-82. PubMed ID: 22120277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
    Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.
    Frank S; Steffens S; Fischer U; Tlolko A; Rainov NG; Kramm CM
    Cancer Gene Ther; 2002 Feb; 9(2):178-88. PubMed ID: 11857036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy.
    Miura F; Moriuchi S; Maeda M; Sano A; Maruno M; Tsanaclis AM; Marino R; Glorioso JC; Yoshimine T
    Gene Ther; 2002 Dec; 9(24):1653-8. PubMed ID: 12457278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
    Määttä AM; Tenhunen A; Pasanen T; Meriläinen O; Pellinen R; Mäkinen K; Alhava E; Wahlfors J
    Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymidine kinase-mediated killing of rat brain tumors.
    Barba D; Hardin J; Ray J; Gage FH
    J Neurosurg; 1993 Nov; 79(5):729-35. PubMed ID: 8410252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rat glioma cell death induced by cationic liposome-mediated transfer of the herpes simplex virus thymidine kinase gene followed by ganciclovir treatment.
    Yoshida T; Mizuno M; Taniguchi K; Nakayashiki N; Wakabayashi T; Yoshida J
    J Surg Oncol; 2001 Jan; 76(1):19-25. PubMed ID: 11223820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Connexin 43-enhanced suicide gene therapy using herpesviral vectors.
    Marconi P; Tamura M; Moriuchi S; Krisky DM; Niranjan A; Goins WF; Cohen JB; Glorioso JC
    Mol Ther; 2000 Jan; 1(1):71-81. PubMed ID: 10933914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.